The Online Investor
Diagnostics M&A image Diagnostics M&A » By The Online Investor Staff, updated Sat., Feb. 29, 1:16 AM Recent mergers and acquisitions in the Diagnostics M&A category.

Slide #81. BC Acquisition Corp. BioClinica

Acquirer: BC Acquisition Corp.
Acquiree: BioClinica (NASDAQ:BIOC)
Details: BioClinica, Inc., a leading global provider of clinical trial management solutions and JLL Partners, Inc., a leading private equity investment firm, announced today that BC Acquisition Corp. ("Purchaser"), which is a wholly-owned subsidiary of BioCore Holdings, Inc. ("Parent"), each of which is an affiliate of JLL, has commenced a tender offer for all outstanding shares of BioClinica at a price of $7.25 per share net to the seller in cash. The offer is being made pursuant to a definitive merger agreement pursuant to which Parent will acquire BioClinica. Parent and Purchaser are affiliates of JLL Partners Fund VI, L.P. (the "Sponsor"), which is a private equity investment fund managed by JLL.



Open the BIOC Page at The Online Investor »

Company Name: 
Biocept Inc
Website: 
www.biocept.com
Sector: 
Biotechnology
Number of ETFs Holding BIOC: 
2
Total Market Value Held by ETFs: 
$71949
Total Market Capitalization: 
$7.00M
% of Market Cap. Held by ETFs: 
1.03%
 

Open the BIOC Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes



Strong Buy (4.00 out of 4)
97th percentile
(ranked higher than approx. 97% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Diagnostics M&A - Slide 81 of 100 Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.